首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007).
【24h】

Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007).

机译:千年后(2000-2007年),全国人群的腹膜透析相关性腹膜炎发生率和结局并未改善。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Peritoneal dialysis (PD)-related peritonitis remains the leading cause of technique failure and a significant cause of morbidity among PD patients. Rates in the literature vary, reflecting differences in study design and in populations. The objective of the present study was to determine peritonitis incidence and outcomes in Scotland and to compare them with national guidelines. METHODS: All 10 adult renal units in Scotland prospectively collect data relating to peritonitis for all PD patients in Scotland. Complete audit data between 1 January 2000 and 31 December 2007 were analyzed for the study. RESULTS: The 1918 peritonitis episodes in 38 106 PD treatment months yielded a national rate of 1 episode every 19.9 months. The UK Renal Association standard was met every year, but is not consistently improving. The median peritonitis-free survival was 526 days (95% confidence interval: 463 to 589 days). The spectrum of causative organisms reflected those in previous reports, with a culture-negative rate of 19.4%. Nationally, the cure rate was 74.6%, the refractory rate was 22.6%, and the death rate was 2.8%. Outcome varied by organism. Recurrences represented 9.3% of episodes, and technique failure occurred in 14.9%. The peritonitis rate was higher for continuous ambulatory PD patients than for automated PD patients (1 episode every 17.6 months vs 1 episode every 22.3 months, p < 0.001, relative risk: 1.27). There were significant differences between renal units. CONCLUSIONS: This large national PD cohort met targets for peritonitis rates every year during the 8 years covered by the present report, but showed no consistent trend for improvement. Peritonitis remains the main cause of technique failure in Scotland. Peritonitis rates varied widely between the units, which suggests that we should look to the units and countries with lower peritonitis rates to see if we can adopt successful elements of their practice before resigning ourselves to our ongoing peritonitis burden.
机译:背景:腹膜透析(PD)相关的腹膜炎仍然是技术失败的主要原因,也是PD患者发病的重要原因。文献中的费率各不相同,反映出研究设计和人群的差异。本研究的目的是确定苏格兰腹膜炎的发生率和结局,并将其与国家指南进行比较。方法:苏格兰的所有10个成年肾脏单位均前瞻性地收集了苏格兰所有PD患者的腹膜炎相关数据。分析了2000年1月1日至2007年12月31日期间的完整审核数据。结果:38 106 PD治疗月中的1918年腹膜炎发作每19.9个月全国发生1次。每年都达到英国肾脏协会的标准,但并没有持续提高。无腹膜炎的中位生存期为526天(95%置信区间:463至589天)。致病菌的光谱反映了以前的报告,培养阴性率为19.4%。在全国范围内,治愈率为74.6%,耐火率为22.6%,死亡率为2.8%。结果因生物体而异。复发占发作的9.3%,发生技术失败的占14.9%。连续非卧床PD患者的腹膜炎发生率高于自动PD患者(每17.6个月发作1次,每22.3个月发作1次,p <0.001,相对危险度:1.27)。肾脏单位之间存在显着差异。结论:在本报告涵盖的8年中,这个庞大的国家PD人群每年均达到腹膜炎发生率的目标,但并没有持续的改善趋势。腹膜炎仍然是苏格兰技术失败的主要原因。单位之间的腹膜炎发生率差异很大,这表明我们应该在腹膜炎负担减轻之前,先看看那些单位和腹膜炎发生率较低的国家,看看我们是否可以采用成功的做法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号